Sarafan ChEM-H


Showing 131-140 of 141 Results

  • Xinnan Wang

    Xinnan Wang

    Professor of Neurosurgery

    Current Research and Scholarly InterestsMechanisms underlying mitochondrial dynamics and function, and their implications in neurological disorders.

  • Robert Waymouth

    Robert Waymouth

    Robert Eckles Swain Professor of Chemistry and Professor, by courtesy, of Chemical Engineering

    BioRobert Eckles Swain Professor in Chemistry Robert Waymouth investigates new catalytic strategies to create useful new molecules, including bioactive polymers, synthetic fuels, and sustainable plastics. In one such breakthrough, Professor Waymouth and Professor Wender developed a new class of gene delivery agents.

    Born in 1960 in Warner Robins, Georgia, Robert Waymouth studied chemistry and mathematics at Washington and Lee University in Lexington, Virginia (B.S. and B.A., respectively, both summa cum laude, 1982). He developed an interest in synthetic and mechanistic organometallic chemistry during his doctoral studies in chemistry at the California Institute of Technology under Professor R.H. Grubbs (Ph.D., 1987). His postdoctoral research with Professor Piero Pino at the Institut fur Polymere, ETH Zurich, Switzerland, focused on catalytic hydrogenation with chiral metallocene catalysts. He joined the Stanford University faculty as assistant professor in 1988, becoming full professor in 1997 and in 2000 the Robert Eckles Swain Professor of Chemistry.

    Today, the Waymouth Group applies mechanistic principles to develop new concepts in catalysis, with particular focus on the development of organometallic and organic catalysts for the synthesis of complex macromolecular architectures. In organometallic catalysis, the group devised a highly selective alcohol oxidation catalyst that selectively oxidizes unprotected polyols and carbohydrates to alpha-hyroxyketones. In collaboration with Dr. James Hedrick of IBM, we have developed a platform of highly active organic catalysts and continuous flow reactors that provide access to polymer architectures that are difficult to access by conventional approaches.

    The Waymouth group has devised selective organocatalytic strategies for the synthesis of functional degradable polymers and oligomers that function as "molecular transporters" to deliver genes, drugs and probes into cells and live animals. These advances led to the joint discovery with the Wender group of a general, safe, and remarkably effective concept for RNA delivery based on a new class of synthetic cationic materials, Charge-Altering Releasable Transporters (CARTs). This technology has been shown to be effective for mRNA based cancer vaccines.

  • William Weis

    William Weis

    Faculty Fellow, Sarafan ChEM-H

    Current Research and Scholarly InterestsOur laboratory studies molecular interactions that underlie the establishment and maintenance of cell and tissue structure. Our principal areas of interest are the architecture and dynamics of intercellular adhesion junctions, signaling pathways that govern cell fate determination, and determinants of cell polarity. Our overall approach is to reconstitute macromolecular assemblies with purified components in order to analyze them using biochemical, biophysical and structural methods.

  • Paul Wender

    Paul Wender

    Francis W. Bergstrom Professor and Professor, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly InterestsMolecular imaging, therapeutics, drug delivery, drug mode of action, synthesis

  • Albert Y. Wu, MD, PhD, FACS

    Albert Y. Wu, MD, PhD, FACS

    Assistant Professor of Ophthalmology

    Current Research and Scholarly InterestsMy translational research focuses on using autologous stem cells to recreate a patient’s ocular tissues for potential transplantation. We are generating tissue from induced pluripotent stem cells to treat limbal stem cell deficiency in patients who are bilaterally blind. By applying my background in molecular and cellular biology, stem cell biology, oculoplastic surgery, I hope to make regenerative medicine a reality for those suffering from orbital and ocular disease.

  • Joseph  C. Wu, MD, PhD

    Joseph C. Wu, MD, PhD

    Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology

    Current Research and Scholarly InterestsDrug discovery, drug screening, and disease modeling using iPSC.

  • Haopeng Xiao

    Haopeng Xiao

    Assistant Professor of Biochemistry

    BioUnderstanding mechanisms of metabolic regulation in physiology and disease forms the basis for developing therapies to treat diseases in which metabolism is perturbed. We devise novel mass spectrometry (MS)-based proteomics technologies, combined with data science, to systematically discover mechanisms of metabolic regulation over protein function. Our strategies established the first tissue-specific landscape of protein cysteine redox regulation during aging, elucidating mechanisms of redox signaling in physiology that remained elusive for decades. We also leverage the genetic diversity of outbred populations to systematically annotate protein function and protein-metabolite co-regulation. The aim of our research program is to develop next-generation MS-based strategies to understand mechanisms of metabolic regulation in aging, metabolic disease, and cancer, and to use this knowledge as a basis to develop translational therapeutics.

  • Priscilla Li-ning Yang

    Priscilla Li-ning Yang

    Professor of Microbiology and Immunology

    Current Research and Scholarly InterestsWe apply chemical biology approaches to study fundamental virological processes and to develop antivirals with novel mechanisms of action.

  • Ellen Yeh

    Ellen Yeh

    Associate Professor of Pathology and of Microbiology and Immunology

    Current Research and Scholarly InterestsOur research program focuses on understudied microbial ecology as solutions for planet health. We select organisms with important functional traits to understand their evolution, role in the environment, and potential for bioengineering toward sustainability solutions. We are currently working on nitrogen-fixing cyanobacteria and algae, genetic screens in diatoms, and algal biofuels.

  • Renee Zhao

    Renee Zhao

    Assistant Professor of Mechanical Engineering and, by courtesy, of Materials Science and Engineering

    BioRuike Renee Zhao is an Assistant Professor of Mechanical Engineering at Stanford University, where she directs the Soft Intelligent Materials Laboratory. Originally from the historic city of Xi'an, she earned her BS from Xi'an Jiaotong University in 2012. She then pursued Solid Mechanics at Brown University, obtaining her MS in 2014 and PhD in 2016. Following her doctoral studies, she completed postdoctoral training at MIT (2016–2018) before serving as an Assistant Professor at The Ohio State University (2018–2021).

    Renee’s research focuses on developing stimuli-responsive soft composites for multifunctional robotic systems with integrated shape-changing, assembly, sensing, and navigation capabilities. By integrating mechanics, material science, and advanced material manufacturing, her work enables innovations in soft robotics, miniaturized biomedical devices, robotic surgery, origami systems, active metamaterials, and general deployable morphing structures.

    Her contributions have been recognized with honors and awards, including the ARO Early Career Program (ECP) Award (2023), AFOSR Young Investigator Research Program (YIP) Award (2023), Eshelby Mechanics Award for Young Faculty (2022), ASME Henry Hess Early Career Publication Award (2022), ASME Pi Tau Sigma Gold Medal (2022), ASME Applied Mechanics Division Journal of Applied Mechanics Award (2021), NSF CAREER Award (2020), and ASME Applied Mechanics Division Haythornthwaite Research Initiation Award (2018). She is also recognized as a National Academy of Sciences Kavli Fellow and was named one of MIT Technology Review's 35 Innovators Under 35.